127 related articles for article (PubMed ID: 6591856)
1. [Differential cell growth inhibition and terminal differentiation induction by chemotherapeutic agents of a human acute myelogenous leukemia cell line (HL-60) in vitro].
Himori T; Ohnuma T; Wakui A
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1605-11. PubMed ID: 6591856
[TBL] [Abstract][Full Text] [Related]
2. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
3. [Drug sensitivity of human acute myelocytic leukemia cells (HL-60) and normal human myelocytes (CFU-C) in a co-culture].
Himori T; Ohnuma T; Wakui A
Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1170-8. PubMed ID: 6575724
[TBL] [Abstract][Full Text] [Related]
4. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
Schwartz EL; Blair OC; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
[TBL] [Abstract][Full Text] [Related]
5. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
Craig RW; Frankfurt OS; Sakagami H; Takeda K; Bloch A
Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapeutic susceptibility of human bone marrow progenitor cells and human myelogenous leukemia cells (HL-60) in co-culture: preliminary report.
Himori T; Ohnuma T; Holland JF
Int J Cell Cloning; 1984 Jul; 2(4):254-62. PubMed ID: 6589302
[TBL] [Abstract][Full Text] [Related]
7. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
Cheng HW; Armstrong RD; Sadée W
Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
[TBL] [Abstract][Full Text] [Related]
8. Induction of differentiation of acute promyelocytic leukemia cells by a cytidine deaminase-resistant analogue of 1-beta-D-arabinofuranosylcytosine, 1-(2-deoxy-2-methylene-beta-D-erythro-pentofuranosyl)cytidine.
Niitsu N; Ishii Y; Matsuda A; Honma Y
Cancer Res; 2001 Jan; 61(1):178-85. PubMed ID: 11196157
[TBL] [Abstract][Full Text] [Related]
9. Enhancement by hemin of the sensitivity of K562 human leukemic cells to 1-beta-D-arabinofuranosylcytosine.
Okabe-Kado J; Hayashi M; Honma Y; Hozumi M
Cancer Res; 1986 Mar; 46(3):1239-43. PubMed ID: 3455882
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships for the induction of differentiation of HL-60 human acute promyelocytic leukemia cells by anthracyclines.
Schwartz EL; Sartorelli AC
Cancer Res; 1982 Jul; 42(7):2651-5. PubMed ID: 6952957
[TBL] [Abstract][Full Text] [Related]
11. Cell proliferation kinetics and drug sensitivity of exponential and stationary populations of cultured L1210 cells.
Bhuyan BK; Fraser TJ; Day KJ
Cancer Res; 1977 Apr; 37(4):1057-63. PubMed ID: 139202
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of proliferation and induction of differentiation of human myeloid leukemia cells by novel nucleoside analogs.
Honma Y; Ikuta T; Kasukabe T; Hozumi M; Itoh T; Ogura H
Anticancer Res; 1988; 8(4):695-9. PubMed ID: 3178159
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a human myelogenous leukemia cell line resistant to 4'-(9-acridinylamino)-3-methanesulfon-m-anisidide.
Beran M; Andersson BS
Cancer Res; 1987 Apr; 47(7):1897-904. PubMed ID: 3469023
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
Schwartz EL; Brown BJ; Nierenburg M; Marsh JC; Sartorelli AC
Cancer Res; 1983 Jun; 43(6):2725-30. PubMed ID: 6573951
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of interaction between DNA-specific antitumor agents and serum-contained cytokines in the initiation of ML-1 human myeloblastic leukemia cell differentiation.
Bloch A
Leukemia; 1993 Aug; 7(8):1219-24. PubMed ID: 8350621
[TBL] [Abstract][Full Text] [Related]
16. Interaction of antileukemia agents adriamycin and daunomycin with sphinganine on the differentiation of human leukemia cell line HL-60.
Yung BY; Luo KJ; Hui EK
Cancer Res; 1992 Jul; 52(13):3593-7. PubMed ID: 1617630
[TBL] [Abstract][Full Text] [Related]
17. Induction of differentiation of human myeloid leukemia cells by inhibitors of DNA synthesis.
Griffin J; Munroe D; Major P; Kufe D
Exp Hematol; 1982 Oct; 10(9):774-81. PubMed ID: 6816625
[TBL] [Abstract][Full Text] [Related]
18. Evidence of multifactorial mechanisms in an adriamycin-resistant HL-60 promyelocytic leukemia cell line.
Burres NS; Myers MT; Sartorelli AC
Cancer Biochem Biophys; 1988 Jul; 10(1):47-57. PubMed ID: 3224331
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells.
Gu C; Ye T; Wells RA
Leuk Res; 2006 Nov; 30(11):1447-51. PubMed ID: 16704876
[TBL] [Abstract][Full Text] [Related]
20. [Effect of cancer chemotherapeutic agents on induction of differentiation of cells and their therapeutic implications].
Hozumi M
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):714-20. PubMed ID: 3457551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]